ASCO GI 2026: Matterhorn

ASCO GI 2026: Matterhorn

Panel of oncology experts discussing next-line treatment strategies for Durvalumab in gastric and GEJ cancer, highlighting clinical insights and practice updates.

ASCO GI 2026: Matterhorn

02/02/2026

Ep. 4: Next-Line Strategies and Practice Insights for Durvalumab in Gastric and GEJ Cancer

Rahul Gosain, MD, MBARohit Gosain, MDAngela Alistar, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD

1. Expert panel on balancing therapy intensity and patient tolerability in gastric cancer featuring OncUpdates specialists.

ASCO GI 2026: Matterhorn

01/31/2026

Ep. 3: Balancing Therapy Intensity and Patient Tolerability in Gastric and GEJ Cancer

Rahul Gosain, MD, MBARohit Gosain, MDAngela Alistar, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD

1. Upfront PD-L1 testing and perioperative immunotherapy for gastric cancer with oncology experts from OncUpdates.

ASCO GI 2026: Matterhorn

01/29/2026

Ep. 2: Up-Front PD-L1 Testing and Perioperative Immunotherapy in Gastric and GEJ Cancer

Rahul Gosain, MD, MBARohit Gosain, MDAngela Alistar, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD

1. Expert medical professionals discussing perioperative dervalimbal in gastric and GEJ cancer for advanced oncology treatment insights.

ASCO GI 2026: Matterhorn

01/27/2026

Ep. 1: Clinical Insights on Perioperative Durvalumab in Gastric and GEJ Cancer

Rahul Gosain, MD, MBARohit Gosain, MDAngela Alistar, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD

1. OncUpdates article on perioperative Durvalumab and FLOT chemotherapy for resectable gastric and GEJ adenocarcinoma featuring expert doctors from OncUpdates.

ASCO GI 2026: Matterhorn

01/21/2026

Perioperative Durvalumab: The New Standard for Gastric or GEJ Cancer

Angela Alistar, MDRahul Gosain, MD, MBARohit Gosain, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD